Performance of lactating crossbred cows on pasture supplemented with conventional urea or slow release urea / Desempenho de vacas mestiças lactantes em pasto suplementadas com ureia convencional ou ureia de liberação lenta

The effect of using conventional urea (CU) or slow release urea (SRU) was evaluated by replacing soybean meal (SBM) in concentrated supplements in levels of 2, 4 or 6% (dry matter basis) on productive performance of crossbred Holstein x Zebu lactating dairy cows (499±61kg body weight and 167 days of lactation) grazing on elephant grass (11.5% CP and 60% NDF) under rotational grazing during the rainy season. A supplement control (no urea) was used containing SBM as a protein source. A total of 21 cows were distributed an incomplete randomized block design with three periods of 21 days each (14 days of adaptation and seven days of collection). The animals entered the paddocks with a pasture height of 110-120cm and left when the grass reached the height of 40-50cm. The concentrated isonitrogenous supplements (24% crude protein, dry matter basis) were provided in the amount of 3.2kg/cow/day (fed basis). There was no effect (P>0.05) on source of crude protein (SBM vs source NPN), source NPN, level of NPN, interaction between source NPN and level of NPN on milk production (10.0kg/day), fat milk production corrected to 3.5% (10.7kg/day), levels of fat (4.01%), protein (3.66%), lactose (4.16%), total solids (12.86%) and non-fat solids (8.60%) in milk. The replacement of CU by SRU does not promote improvement in the productive performance of crossbred dairy cows grazing on elephant grass during the rainy season. Urea (CU or SRU) can be included in up to 6% of the DM concentrated supplements, replacing SBM, without affecting the productive performance of crossbred cows (Holstein x Zebu) in pasture during the rainy season...

Avaliou-se o efeito da utilização de ureia convencional (UC) ou de ureia de liberação lenta (ULL) em suplementos concentrados, nos níveis de 2, 4 ou 6% (base da matéria seca), em substituição ao farelo de soja, sobre o desempenho produtivo de vacas mestiças Holandês x Zebu (499±61kg de peso corporal e 167 dias de lactação) mantidas em pastos de capim-elefante (11,5% de proteína bruta e 60% de FDNcp), sob lotação intermitente, no período das chuvas. Um suplemento controle (sem ureia) foi utilizado contendo farelo de soja como fonte proteica. Foram utilizadas 21 vacas, distribuídas em delineamento em blocos incompletos balanceados, com três períodos de 21 dias cada (14 dias de adaptação e sete dias de coleta). Os animais entraram nos piquetes com altura do pasto de 110-120cm e saíram quando atingiram altura de 40-50cm. Os suplementos concentrados isonitrogenados (24% de proteína bruta, base da matéria seca) foram fornecidos na quantidade de 3,2kg/vaca/dia (base da matéria natural). Não houve efeito (P>0,05) de fonte de proteína bruta (farelo de soja vs. fonte de NNP), de interação entre fonte de NNP (UC vs. ULL) e nível de NNP (2, 4 e 6% na MS do suplemento), de fonte de NNP e de nível de NNP e sobre a produção de leite (10,0kg/dia), produção de leite corrigida para 3,5% de gordura (10,7kg/dia), teores de gordura (4,01%), proteína (3,66%), lactose (4,16%), extrato seco total (12,86%) e extrato seco desengordurado (8,60%) no leite. A substituição da ureia convencional pela ULL não promove melhoria no desempenho produtivo de vacas leiteiras mestiças em pastagem de capim-elefante, no período das chuvas. A ureia (convencional ou de liberação lenta) pode ser incluída em até 6% na MS de suplementos concentrados, em substituição ao farelo de soja, sem afetar o desempenho produtivo de vacas mestiças (Holandês x Zebu) em pastagem, no período das chuvas...

Changes in AgNOR configurations during the evolution and treatment of chronic lymphocytic leukemia.

The evolution of the pattern of nucleolar organiser regions (AgNORs) in circulating lymphocytes during the stable phase and after chemotherapy in CLL was analysed. Peripheral blood smears were stained by the AgNOR technique at diagnosis, during observation follow-up in stable phase, or at the beginning and at the end of chemotherapy in patients with progressive disease. The changes in the AgNOR pattern were compared with those of TTM used as a tumour burden parameter. Among 52 cases that entered the study, 29 were in stable phase and 23 had progressive disease and received chemotherapy. During stable phase, the AgNORs as well as TTM remained constant. In treated patients, the relative reduction of tumour mass was correlated with a decrease in the percentage of lymphocytes containing one AgNOR cluster. The percentage of cells with one compact nucleolus before chemotherapy was inversely correlated with the relative amount of tumor reduction after treatment. We conclude that the AgNOR pattern in CLL describes the cell kinetic changes during the evolution of the disease and is a prognostic factor for tumor reduction after treatment.

Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil.

The prevalence of the prothrombin gene variant (allele 20.210 A), factor V Leiden mutation, and homozygosity for transition 677C-->T in the methylenetetrahydrofolate reductase (MTHFR) gene was determined among patients with sickle cell disease (SCD). The group included 73 patients with median age of 32.3 years with a diagnosis of sickle cell anemia in 53 patients, hemoglobinopathy SC in 16 patients, and four with S/beta(0) thalassemia. Vascular complications such as ischemic stroke or deep vein thrombosis were diagnosed in nine patients. Heterozygosity for the prothrombin gene variant or factor V Leiden mutation was identified in four patients. However, only one patient, who developed ischemic stroke, was identified as a carrier of factor V Leiden mutation. None of the patients presented homozygosity for the thermolabile variant of the MTHFR. These data suggest a low clinical impact of inherited hypercoagulability risk factors in developing thrombosis, occlusive stroke, or mortality data among patients with SCD in Brazil.

Genetic investigations in a Northern Brazilian island. II. Random drift.

18 albinos were born on Lençóis island. Since 3 of them died and 5 emigrated, the prevalence of albinism is about 3% in the island. 2 inbred brothers with brachydactyly of the index fingers and 1 case of 'achondroplasia' were also found. The analysis of the population structure of the island suggests that its high frequency of albinism may have been produced by random drift. The index of isolation of its present population is roughly 17--27. Genealogical, clinical and histological data are presented and anslyzed. Natural selection is not acting against the albinism gene at a measurable rate. Cytogenetic investigations among albinos and normals did not reveal any difference as regards frequency of aneuploidy, association of acrocentrics and chromatid gaps. The role of random processes in evolution is mentioned and the possibility that they may be more important than it is sometimes assumed is stressed.